Medindia
Medindia LOGIN REGISTER
Advertisement

Rubicor Medical, Inc. Receives $10 Million in Financing to Further Growth Opportunity

Monday, August 27, 2007 General News
Advertisement
REDWOOD CITY, Calif., Aug. 27 Rubicor Medical Inc., aprivately-held medical device company which develops and markets minimallyinvasive technologies for breast biopsy and tissue removal, announced todaythat it has entered into a $10 million loan agreement with lenders ComericaBank and Oxford Finance Corporation. The venture debt credit facilities willbe used by Rubicor to support its ongoing working capital requirements,capital expenditures and other corporate growth initiatives.
Advertisement

"We were extremely pleased with the financing solution that Oxford andComerica developed," commented James Vetter, Rubicor Founder and CEO. "Theadditional financing will allow us to further our goal to provide technologiesthat exceed the standards of care in breast disease management for both ourphysicians and patients."
Advertisement

The DiBari Group, LLC acted as advisor for the Company in connection withthis transaction.

"We were delighted to work with such an experienced management team atRubicor in putting this financing together which provides the company withincreased resources to realize accelerated growth in the coming year,"commented Rob Winkelmann, Managing Partner and CEO of the DiBari Group.

About Rubicor Medical, Inc.

Rubicor Medical Inc. is a privately-held medical device company focused ondeveloping and marketing single use, minimally-invasive breast biopsy andtissue removal technologies. The Company was founded in 1998 by interventionalcardiologist James Vetter, M.D., and is based in Redwood City, CA. TheCompany currently markets three disposable devices for breast biopsy andsurgery -- Flash(TM), Phantom(TM) and Halo(TM). The Flash technology allowsfor single insertion, multi-sampling, core biopsy for breast lesion diagnosiswithout having to re-insert the device into the breast. Phantom providessurgeons with a revolutionary soft-tissue excision device for breast surgicalprocedures, and is the first percutaneous device to excise and remove breastlesions. The third device, Halo, empowers physicians to capture completebreast tissue abnormalities through a minimally-invasive procedure in theiroffice exam rooms.

About The DiBari Group, LLC

The DiBari Group is a financial advisory and consulting firm dedicated toprocuring debt capital for both public and private companies in various stagesof development. The firm has supported high growth companies for over 10 yearswith an emphasis in communication, software, technology, healthcare and lifesciences. For more information visit http://www.dibarigroup.com.

About Oxford Finance

Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, is aspecialty finance firm providing senior secured loans to public and privatelife science companies worldwide. For nearly twenty years, it has deliveredflexible financing solutions to its clients, enabling them to maximize theirequity by leveraging their assets. In recent years, Oxford has originatedover $600 million in loans, with lines of credit ranging from $100 thousand to$20 million. Oxford is headquartered in Alexandria, Virginia, with additionaloffices in California and Massachusetts. For more information, visithttp://www.oxfordfinance.com.

About Comerica Bank's Technology & Life Sciences Division

Comerica Bank's Technology & Life Sciences Division is one of the nation'sleading technology banking practices, offering a wide range of financialservices tailored to corporate customers, entrepreneurs and professionals.Veteran bankers provide credit and financial services and products to young,growing, professionally backed technology and life sciences companies, as wellas their more mature counterparts. The Technology & Life Sciences Divisionserves all major U.S. technology centers from offices coast-to-coast and itsheadquarters in Palo Alto, Calif. Comerica Bank is a subsidiary of ComericaIncorporated (
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close